Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has announced the issuance of 149,925,040 unquoted equity securities, specifically options expiring on February 24, 2025, with an exercise price of $0.05. The move, dated August 23, 2024, is part of a transaction previously communicated to the market and will not result in the options being quoted on the ASX.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
